ECSP034692A - Antagonistas de receptores de histamina - Google Patents

Antagonistas de receptores de histamina

Info

Publication number
ECSP034692A
ECSP034692A EC2003004692A ECSP034692A ECSP034692A EC SP034692 A ECSP034692 A EC SP034692A EC 2003004692 A EC2003004692 A EC 2003004692A EC SP034692 A ECSP034692 A EC SP034692A EC SP034692 A ECSP034692 A EC SP034692A
Authority
EC
Ecuador
Prior art keywords
histamine
receptor
receiver antagonists
histamine receiver
antagonists
Prior art date
Application number
EC2003004692A
Other languages
English (en)
Inventor
Stephen Jenkinson
Mark Anthony O'reilly
Michael Andrew Trevethick
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ECSP034692A publication Critical patent/ECSP034692A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención proporciona una combinación de (a) un antagonista de receptor H1 de histamina y (b) un antagonista que es al menos 10 veces más selectivo para el receptor H4 de histamina en comparación con el receptor H3 de histamina que es al menos 10 veces más selectivo para el receptor H4 de histamina en comparación con el receptor 3 de histamina; y sus composiciones y usos.
EC2003004692A 2001-01-17 2003-07-17 Antagonistas de receptores de histamina ECSP034692A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0101223.6A GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists

Publications (1)

Publication Number Publication Date
ECSP034692A true ECSP034692A (es) 2003-08-29

Family

ID=9906993

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004692A ECSP034692A (es) 2001-01-17 2003-07-17 Antagonistas de receptores de histamina

Country Status (31)

Country Link
EP (1) EP1353657A1 (es)
JP (1) JP2004517883A (es)
KR (1) KR20030069216A (es)
CN (1) CN1486178A (es)
AP (1) AP2002002401A0 (es)
AR (1) AR032101A1 (es)
BG (1) BG107834A (es)
BR (1) BR0206502A (es)
CA (1) CA2435121A1 (es)
CR (1) CR6983A (es)
CZ (1) CZ20031853A3 (es)
DO (1) DOP2002000325A (es)
EA (1) EA200300537A1 (es)
EC (1) ECSP034692A (es)
EE (1) EE200300335A (es)
GB (1) GB0101223D0 (es)
GT (1) GT200200003A (es)
HU (1) HUP0302767A2 (es)
IL (1) IL156087A0 (es)
IS (1) IS6818A (es)
MA (1) MA26980A1 (es)
MX (1) MXPA03006408A (es)
NO (1) NO20033223D0 (es)
OA (1) OA12440A (es)
PA (1) PA8537101A1 (es)
PL (1) PL362793A1 (es)
SK (1) SK8572003A3 (es)
SV (1) SV2003000849A (es)
TN (1) TNSN02003A1 (es)
WO (1) WO2002056871A2 (es)
ZA (1) ZA200304180B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133931A1 (en) * 2001-12-21 2003-07-17 Robin Thurmond Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
JP2006510590A (ja) * 2002-09-06 2006-03-30 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ アレルギー及び喘息の処置のためのヒスタミンh4受容体モジュレーターの使用
US20050090527A1 (en) * 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US8236786B2 (en) 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
DK2858647T3 (en) 2012-06-08 2018-08-20 Sensorion H4 RECEPTOR INHIBITORS FOR TINNITUS TREATMENT
CN119823227B (zh) * 2025-01-14 2025-07-04 广州迪卡德营养科技有限公司 一种益生菌的制备方法及其在治疗过敏性鼻炎中的用途

Also Published As

Publication number Publication date
IS6818A (is) 2003-05-15
IL156087A0 (en) 2003-12-23
NO20033223L (no) 2003-07-16
HUP0302767A2 (hu) 2003-11-28
AP2002002401A0 (en) 2002-03-31
PL362793A1 (en) 2004-11-02
CZ20031853A3 (cs) 2004-07-14
EP1353657A1 (en) 2003-10-22
CR6983A (es) 2003-11-25
OA12440A (en) 2006-05-22
GB0101223D0 (en) 2001-02-28
BR0206502A (pt) 2003-10-21
GT200200003A (es) 2002-08-19
AR032101A1 (es) 2003-10-22
BG107834A (bg) 2004-01-30
EE200300335A (et) 2003-12-15
EA200300537A1 (ru) 2004-02-26
MXPA03006408A (es) 2003-10-15
CN1486178A (zh) 2004-03-31
SV2003000849A (es) 2003-01-13
NO20033223D0 (no) 2003-07-16
SK8572003A3 (en) 2004-07-07
CA2435121A1 (en) 2002-07-25
WO2002056871A2 (en) 2002-07-25
TNSN02003A1 (fr) 2005-12-23
JP2004517883A (ja) 2004-06-17
PA8537101A1 (es) 2002-08-29
KR20030069216A (ko) 2003-08-25
ZA200304180B (en) 2004-06-15
MA26980A1 (fr) 2004-12-20
DOP2002000325A (es) 2003-01-31

Similar Documents

Publication Publication Date Title
AU3652102A (en) Compounds and their uses
PA8567001A1 (es) Composicion de ziprasidona y controles sinteticos
PA8527201A1 (es) Peptidos ciclados con actividad agonista para el receptor de la melanocortina-4 (mc4-r)
DE60222396D1 (de) N-(2-arylethyl) benzylamine als 5-ht6 rezeptor-antagoniste
NO993350L (no) Vitronectin-reseptor-antagonister
LV12639B (lv) Bifenilsulfonamidi ka duali angiotenzina un endotelina receptoru antagonisti
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
MX9302618A (es) Antagonistas de endotelina de fenil sulfonamidas.
ECSP034830A (es) Derivados sustituidos de la ciclohexano-1,4- diamina
ECSP045274A (es) N-aminoacetil-pirrolidina-2-carbonitrilosy su uso como inhibidores ddp-iv
PT1305286E (pt) Ciclopentanoindoles composicoes que contem os referidos compostos e metodos de tratamento
IL155236A0 (en) Association of the cb1 receptor antagonist and a sibutramin, pharmaceutical compositions containing same and use thereof for treating obesity
HN2002000299A (es) Derivados del 3- azabiciclo[3.1.0] hexano
MXPA03010158A (es) Sulfonamidas.
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
DOP2002000325A (es) Antagonistas de receptores de histamina
ATE385799T1 (de) Zusammensetzung einer natriumkanal-blockierenden verbindung
ECSP034558A (es) Moduladores del receptor estrogeno
AR031356A1 (es) Compuesto lacta mico
ECSP034532A (es) Derivados del 1-aminobutan-3-ol sustituido
UY27124A1 (es) Antagonistas de receptores de histamina
PT1406888E (pt) Compostos de y-lactona substituida que servem como antagonistas de nmda
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
ES2155187T3 (es) Antagonistas biciclicos de taquicinas, preparacion de estos antagonistas y su utilizacion en compuestos farmaceuticos.
DE60319399D1 (de) Pharmazeutische kombination von tenatoprazole und einem histamin-h2-rezeptor antagonisten